Skip to main content
Top
Published in: BMC Psychiatry 1/2014

Open Access 01-12-2014 | Research article

Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China

Authors: Zuowei Wang, Keming Gao, Wu Hong, Mengjuan Xing, Zhiguo Wu, Jun Chen, Chen Zhang, Chengmei Yuan, Jia Huang, Daihui Peng, Yong Wang, Weihong Lu, Zhenghui Yi, Xin Yu, Jingping Zhao, Yiru Fang

Published in: BMC Psychiatry | Issue 1/2014

Login to get access

Abstract

Background

With the recent attention to evidence-based medicine in psychiatry, a number of treatment guidelines for bipolar disorders have been published. This survey investigated prescribing patterns and predictors for guideline disconcordance in the acute treatment of a manic and mixed episode across mainland China.

Methods

The pharmacological treatments of 2828 patients with a recent hypomanic/manic episode or mixed state were examined. Guidelines disconcordance was determined by comparing the medication(s) patients were prescribed with the recommendation(s) in the guidelines of the Canadian Network for Mood and Anxiety Treatments.

Results

The most common pattern of pharmacological treatments for an acute manic or mixed episode was a mood stabilizer plus an atypical antipsychotic (n = 1345, 47.6%), and the rate of guideline-disconcordant treatments was 11.1%. The patients who were treated in general hospitals were more likely to receive guideline-disconcordant treatments than those who were treated in psychiatric hospitals, with an OR of 1.84 (95% CI 1.44-2.36). Similarly, the patients with a mixed episode at study entry were more likely to receive guideline-disconcordant treatments than those with a manic episode, with an OR of 1.69 (95% CI 1.22-2.35). In contrast, the patients with a longer duration of disease (>5 years) were less likely to receive guideline-disconcordant treatments than those with a short duration, with an OR of 0.47 (95% CI 0.36-0.60).

Conclusions

In mainland China, the disconcordance with treatment guidelines for a most recent acute manic or mixed episode was modest under naturalistic conditions. The higher risk for disconcordance in general hospitals than in psychiatric hospitals suggests that special education based on treatment guidelines to practitioners in general hospitals is necessary in order to reduce the risk for disconcordant treatments.
Literature
1.
go back to reference Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC: Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007, 64: 543-552. 10.1001/archpsyc.64.5.543.CrossRefPubMedPubMedCentral Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC: Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007, 64: 543-552. 10.1001/archpsyc.64.5.543.CrossRefPubMedPubMedCentral
2.
go back to reference Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68: 241-251. 10.1001/archgenpsychiatry.2011.12.CrossRefPubMedPubMedCentral Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68: 241-251. 10.1001/archgenpsychiatry.2011.12.CrossRefPubMedPubMedCentral
3.
go back to reference Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D: Costs of bipolar disorder. Pharmacoeconomics. 2003, 21: 601-622. 10.2165/00019053-200321090-00001.CrossRefPubMed Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D: Costs of bipolar disorder. Pharmacoeconomics. 2003, 21: 601-622. 10.2165/00019053-200321090-00001.CrossRefPubMed
4.
go back to reference Dilsaver SC: An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord. 2011, 129: 79-83. 10.1016/j.jad.2010.08.030.CrossRefPubMed Dilsaver SC: An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord. 2011, 129: 79-83. 10.1016/j.jad.2010.08.030.CrossRefPubMed
5.
go back to reference Osby U, Brandt L, Correia N, Ekbom A, Sparén P: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001, 58: 844-850. 10.1001/archpsyc.58.9.844.CrossRefPubMed Osby U, Brandt L, Correia N, Ekbom A, Sparén P: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001, 58: 844-850. 10.1001/archpsyc.58.9.844.CrossRefPubMed
6.
go back to reference Kupfer DJ: The increasing medical burden in bipolar disorder. JAMA. 2005, 293: 2528-2530. 10.1001/jama.293.20.2528.CrossRefPubMed Kupfer DJ: The increasing medical burden in bipolar disorder. JAMA. 2005, 293: 2528-2530. 10.1001/jama.293.20.2528.CrossRefPubMed
7.
go back to reference Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML, Carmody TJ, Kashner TM: Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? results from the Texas Medication Algorithm Project. Psychol Med. 2005, 35: 1695-1706. 10.1017/S0033291705005933.CrossRefPubMed Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML, Carmody TJ, Kashner TM: Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? results from the Texas Medication Algorithm Project. Psychol Med. 2005, 35: 1695-1706. 10.1017/S0033291705005933.CrossRefPubMed
8.
go back to reference Bauer MS, Biswas K, Kilbourne AM: Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. Am J Psychiatry. 2009, 166: 1244-1250. 10.1176/appi.ajp.2009.09030342.CrossRefPubMed Bauer MS, Biswas K, Kilbourne AM: Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. Am J Psychiatry. 2009, 166: 1244-1250. 10.1176/appi.ajp.2009.09030342.CrossRefPubMed
9.
go back to reference American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002, 159 (4 Suppl): 1-50. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002, 159 (4 Suppl): 1-50.
10.
go back to reference National Collaborating Center for Mental Health (UK): Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Second Care. 2006, Leicester (UK): British Psychological Society National Collaborating Center for Mental Health (UK): Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Second Care. 2006, Leicester (UK): British Psychological Society
11.
go back to reference Shen QJ, Liu TB, Zhang HY, Ma X, Wang GH, Tian CH, Li HF, Wang XD, He YL, Zheng HB, Hao W, Zhao JP, Yang HC: Practice guideline for prevention and treatment of bipolar disorder (in Chinese). 2007, Beijing (China): Chinese Medical Association Shen QJ, Liu TB, Zhang HY, Ma X, Wang GH, Tian CH, Li HF, Wang XD, He YL, Zheng HB, Hao W, Zhao JP, Yang HC: Practice guideline for prevention and treatment of bipolar disorder (in Chinese). 2007, Beijing (China): Chinese Medical Association
12.
go back to reference Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009, 10: 85-116. 10.1080/15622970902823202.CrossRefPubMed Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009, 10: 85-116. 10.1080/15622970902823202.CrossRefPubMed
13.
go back to reference Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, WFSBP Task Force On Treatment Guidelines For Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010, 11: 81-109. 10.3109/15622970903555881.CrossRefPubMed Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, WFSBP Task Force On Treatment Guidelines For Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010, 11: 81-109. 10.3109/15622970903555881.CrossRefPubMed
14.
go back to reference Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013, 14: 154-219. 10.3109/15622975.2013.770551.CrossRefPubMed Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013, 14: 154-219. 10.3109/15622975.2013.770551.CrossRefPubMed
15.
go back to reference Mok YM, Chan HN, Chee KS, Chua TE, Lim BL, Marziyana AR, Peh LH, Song CH, Tung YC, Yap P, Yong M, Ministry of Health: Ministry of Health clinical practice guidelines: bipolar disorder. Singapore Med J. 2011, 52: 914-918.PubMed Mok YM, Chan HN, Chee KS, Chua TE, Lim BL, Marziyana AR, Peh LH, Song CH, Tung YC, Yap P, Yong M, Ministry of Health: Ministry of Health clinical practice guidelines: bipolar disorder. Singapore Med J. 2011, 52: 914-918.PubMed
16.
go back to reference Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013, 15: 1-44.CrossRefPubMed Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013, 15: 1-44.CrossRefPubMed
17.
go back to reference Geddes JR, Miklowitz DJ: Treatment of bipolar disorder. Lancet. 2013, 381: 1672-1682. 10.1016/S0140-6736(13)60857-0.CrossRefPubMed Geddes JR, Miklowitz DJ: Treatment of bipolar disorder. Lancet. 2013, 381: 1672-1682. 10.1016/S0140-6736(13)60857-0.CrossRefPubMed
18.
go back to reference Farrelly N, Dibben C, Hunt N: Current management of bipolar affective disorder: is it reflective of the BAP guidelines?. J Psychopharmacol. 2006, 20: 128-131.PubMed Farrelly N, Dibben C, Hunt N: Current management of bipolar affective disorder: is it reflective of the BAP guidelines?. J Psychopharmacol. 2006, 20: 128-131.PubMed
19.
go back to reference Dennehy EB, Bauer MS, Perlis RH, Kogan JN, Sachs GS: Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull. 2007, 40: 72-84.PubMed Dennehy EB, Bauer MS, Perlis RH, Kogan JN, Sachs GS: Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull. 2007, 40: 72-84.PubMed
20.
go back to reference Paterniti S, Bisserbe JC: Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. BMC Psychiatry. 2013, 13: 211-10.1186/1471-244X-13-211.CrossRefPubMedPubMedCentral Paterniti S, Bisserbe JC: Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. BMC Psychiatry. 2013, 13: 211-10.1186/1471-244X-13-211.CrossRefPubMedPubMedCentral
21.
go back to reference Samalin L, Guillaume S, Auclair C, Llorca PM: Adherence to guidelines by French psychiatrists in their real world of clinical practice. J Nerv Ment Dis. 2011, 199: 239-243. 10.1097/NMD.0b013e3182125d4c.CrossRefPubMed Samalin L, Guillaume S, Auclair C, Llorca PM: Adherence to guidelines by French psychiatrists in their real world of clinical practice. J Nerv Ment Dis. 2011, 199: 239-243. 10.1097/NMD.0b013e3182125d4c.CrossRefPubMed
22.
go back to reference Perlis RH: Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Curr Med Res Opin. 2007, 23: 467-475. 10.1185/030079906X167444.CrossRefPubMed Perlis RH: Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Curr Med Res Opin. 2007, 23: 467-475. 10.1185/030079906X167444.CrossRefPubMed
23.
go back to reference Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z: Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009, 373: 2041-2053. 10.1016/S0140-6736(09)60660-7.CrossRefPubMed Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z: Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009, 373: 2041-2053. 10.1016/S0140-6736(09)60660-7.CrossRefPubMed
24.
go back to reference Wolfsperger M, Greil W, Rössler W, Grohmann R: Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord. 2007, 99: 9-17. 10.1016/j.jad.2006.08.017.CrossRefPubMed Wolfsperger M, Greil W, Rössler W, Grohmann R: Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord. 2007, 99: 9-17. 10.1016/j.jad.2006.08.017.CrossRefPubMed
25.
go back to reference Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA: Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010, 71: 1176-1186. 10.4088/JCP.08m04811yel.CrossRefPubMed Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA: Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010, 71: 1176-1186. 10.4088/JCP.08m04811yel.CrossRefPubMed
Metadata
Title
Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China
Authors
Zuowei Wang
Keming Gao
Wu Hong
Mengjuan Xing
Zhiguo Wu
Jun Chen
Chen Zhang
Chengmei Yuan
Jia Huang
Daihui Peng
Yong Wang
Weihong Lu
Zhenghui Yi
Xin Yu
Jingping Zhao
Yiru Fang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2014
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-14-167

Other articles of this Issue 1/2014

BMC Psychiatry 1/2014 Go to the issue